Free Trial
OTCMKTS:ENZN

Enzon Pharmaceuticals (ENZN) Stock Price, News & Analysis

Enzon Pharmaceuticals logo
$0.10 0.00 (-1.33%)
As of 07/11/2025 03:48 PM Eastern

About Enzon Pharmaceuticals Stock (OTCMKTS:ENZN)

Key Stats

Today's Range
$0.09
$0.11
50-Day Range
$0.06
$0.13
52-Week Range
$0.06
$0.24
Volume
22,794 shs
Average Volume
129,825 shs
Market Capitalization
$7.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ENZN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ENZN Stock News Headlines

Enzon Pharmaceuticals, Inc. (ENZN) - Yahoo Finance
AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
Enzon and Viskase Enter into Merger Agreement
ENZN Enzon Pharmaceuticals, Inc.
See More Headlines

ENZN Stock Analysis - Frequently Asked Questions

Enzon Pharmaceuticals' stock was trading at $0.1561 at the start of the year. Since then, ENZN stock has decreased by 38.4% and is now trading at $0.0962.

Enzon Pharmaceuticals Inc. (OTCMKTS:ENZN) announced its quarterly earnings results on Friday, May, 9th. The biotechnology company reported ($0.01) earnings per share for the quarter.

Shares of ENZN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Enzon Pharmaceuticals investors own include Biocept (BIOC), Aeterna Zentaris (AEZS), Energy Transfer (ET), DURECT (DRRX), Nymox Pharmaceutical (NYMX), OpGen (OPGN) and BioCryst Pharmaceuticals (BCRX).

Company Calendar

Last Earnings
5/09/2025
Today
7/12/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:ENZN
Previous Symbol
NASDAQ:ENZN
CIK
727510
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$780 thousand
Net Margins
N/A
Pretax Margin
1,150.00%
Return on Equity
-22.19%
Return on Assets
-1.28%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
82.17
Quick Ratio
82.17

Sales & Book Value

Annual Sales
$30 thousand
Price / Sales
237.97
Cash Flow
$0.01 per share
Price / Cash Flow
9.30
Book Value
$0.04 per share
Price / Book
2.41

Miscellaneous

Outstanding Shares
74,210,000
Free Float
73,918,000
Market Cap
$7.14 million
Optionable
Not Optionable
Beta
0.36

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (OTCMKTS:ENZN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners